Skip to content

Repeated transcranial magnetic cerebellum stimulation to improve multi-system atrophic ataxia

Repeated transcranial magnetic cerebellum stimulation to improve multi-system atrophic ataxia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085610
Enrollment
Unknown
Registered
2024-06-13
Start date
2024-01-03
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple system atrophy

Interventions

Sponsors

Baotou Central Hospital, No.61 Huancheng Road, Donghe District, Baotou City, Inner Mongolia Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed with probable MSA-C according to the latest 2022 multi-system atrophy diagnostic criteria; (2) Aged 30-75 years old; (3) Clinical fatigue :FSS-9 score is greater than 36. (4) No other neurodegenerative diseases. Informed and consented by the patient and approved by the Medical Ethics Association.

Exclusion criteria

Exclusion criteria: (1) neurological disease is unstable or accompanied by medical disease. (2) Screening for clinically significant abnormalities (such as basic laboratory tests or electrocardiogram abnormalities). (3) Concurrent participation in another clinical study, history of substance abuse, mental illness, legal incapacity or limited legal capacity. (4) Head metal, history of neurosurgery, ferromagnetic biological implants, metal coatings, history of seizures, claustrophobia, current use of bupropion or other medications that may increase the risk of TMS induced seizures. (5) Pregnancy test positive. (6) Summary mental status examination score (MMSE)=24.

Design outcomes

Primary

MeasureTime frame
Scale for the Assessment and Rating of Ataxia, SARA;

Secondary

MeasureTime frame
Fatigue Severity Scale-9, FSS-9;Hamilton Anxiety Scale, HAMA;Hamilton Depression Scale-24, HAMD-24;

Countries

China

Contacts

Public ContactJinfeng Zhang

Baotou Central Hospital, No.61 Huancheng Road, Donghe District, Baotou City, Inner Mongolia Autonomous Region

rose790310@163.com+86 150 2471 6109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026